Derm Research @ 888 Inc. Report issue

Foundation Phase 4
Founded: Vancouver BC Canada

Organization Overview

First Clinical Trial
2004
NCT00240513
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

DermResearch @ 888 Inc.

Active Ingredients

Drugs in Phase 4 Trials (3)

imiquimod (aldara) (1 trial)

minocycline (minocin) (1 trial)

tretinoin (Retin-A) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3